Navigating Pregnancy and Parenthood With Lyme Disease (NCT06397794)
Mixed Methods Study on Navigating Pregnancy and Parenthood With Lyme Disease
๐ฉบ Plain-English Summary (8th-Grade Level)
This is a mixed methods study exploring the experiences of pregnancy and parenting among participants with Lyme disease. Eligible participants will have been diagnosed with Lyme disease (LD), post-treatment Lyme disease syndrome (PTLDS), and/or chronic Lyme (CL) either during or before a prior pregnancy. Participants will complete quantitative surveys on topics such as their medical history, their child(ren)'s development, and demographic information. They will then participate in a qualitative interview where they will be asked about their experiences with pregnancy and with parenting their child(ren) in the context of their condition.
Who can join: Review the eligibility criteria below.
Location: Children's National Hospital โ Washington D.C., District of Columbia
Age range: 18 Years
๐งช Interventions in This Study
- Quantitative surveys and qualitative interview (OTHER)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Children's National Hospital โ Washington D.C., District of Columbia
๐ Contact the Study Coordinator
Phone: (202) 476-3388
Email: mewilliams@childrensnational.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lyme Disease
- A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure โ Pikesville, Maryland
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age) โ Truro, Nova Scotia
- A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine โ Bangor, Maine
- Evaluation, Treatment, and Follow-up of Patients With Lyme Disease โ Bethesda, Maryland
- Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure โ Washington D.C., District of Columbia
- A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations โ Bethesda, Maryland
Explore by condition: All Lyme Disease clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.